The Canadian Cancer Research Alliance (CCRA) is an alliance of organizations that collectively fund most of the cancer research conducted in Canada – research that will lead to:

  • better ways to prevent cancer
  • diagnose cancer
  • treat cancer and
  • improve patient and survivor outcomes.

Members include federal research funding programs/agencies, provincial research agencies, provincial cancer care agencies, cancer charities, and other voluntary associations. 

We are motivated by the belief that, through effective collaboration, Canadian cancer research funding organizations can maximize their collective impact on cancer control and accelerate discovery for the ultimate benefit of Canadians affected by cancer.

Our Executive Office is supported by the Canadian Partnership Against Cancer, an independent, not-for-profit organization funded by the federal government to accelerate action on cancer control for all Canadians. For more information on the Partnership’s role, click here.

The CCRA is not a registered charity and cannot accept donations. If you wish to donate to a charity that funds cancer research, please check our Members page.


  • has been publishing reports on the annual investment in cancer research in Canada since 2007 (to access, click here)
  • also publishes research investment reports on childhood and adolescent cancers, cancer risk and prevention, early translation, survivorship, and palliative and end-of-life care (to access, click here)
  • has developed two pan-Canadian cancer research strategies, which identify key priorities for cancer research funding collaboration (to access, click here)
  • has produced specific research frameworks for prevention, survivorship, and palliative and end-of-life care, as well as a report on the state of cancer clinical trials in Canada (to access, click here)
  • CCRA’s publications have been cited in more than 50 scientific papers (for a listing of these papers, click here)
  • has convened three scientific conferences, with the fourth scheduled for November 2017 in Vancouver (for more information, click here)
  • recognizes, on a biennial basis, the accomplishments of key leaders in cancer research (for more information, click here).

CCRA Awardees for 2017

CCRA is proud to announce the recipients of the 2017 awards: Dr. Elizabeth Eisenhauer (Queen's University) will receive the Exceptional Leadership in Cancer Research award, Dr. John Bell (University of Ottawa and The Ottawa Hospital) and Dr. Marco Marra (The University of British Columbia and BC Cancer Agency) will receive the Outstanding Achievements in Cancer Research award, Dr. Eduardo Franco (McGill University) will receive the Distinguished Service to Cancer Research award, and Dr. Michael A.S. Jewett (University of Toronto and Princess Margaret Cancer Centre) and Ms. Judy Needham (Canadian Cancer Trials Group and Canadian Cancer Clinical Trials Network) will receive the Exceptional Leadership in Patient Involvement in Cancer award.

The awards will be presented at the 2017 Canadian Cancer Research Conference, which will be held from November 5 to 7, 2017 in Vancouver. For more information, click here.

Celebrating Dr. Connie Eaves

Join us for the Celebration of Science Public Lecture. Monday November 6th, 17:30 Vancouver Convention Centre East Ballroom A & B. How has the work of a Canadian cancer researcher helped to advance our knowledge of cancer and improve outcomes for cancer patients? This public lecture celebrates the scientific accomplishments of Dr. Connie J. Eaves, Distinguished Scientist, Terry Fox Laboratory, BC Cancer Agency and Professor, Medical Genetics at The University of British Columbia. This inspirational evening will help you to better understand Dr. Eaves’ work and how our understanding of cancer has evolved over the past half century. To access the program, click here.

Dr. Elizabeth Eisenhauer Retires

After nearly a decade of leadership as the Co-Chair of CCRA, Dr. Elizabeth Eisenhauer retired on June 30th. Dr. Stephen Robbins, on behalf of the CCRA membership, acknowledged Dr. Eisenhauer’s extraordinary contribution in facilitating the growth and formalizing the mandate of the Alliance.

Dr. Eisenhauer joined as Co-Chair in 2008 and soon afterwards recognized the need to develop a pan-Canadian cancer research strategy that would unite cancer research funders around common areas of interest and help advance the science. The Pan-Canadian Cancer Research Strategy was a landmark document in the evolution of the Alliance’s efforts to facilitate collaboration around important research areas. Dr. Eisenhauer also wrote the seminal Report on the State of Cancer Clinical Trials in Canada, which laid the foundation for the creation of the Canadian Cancer Clinical Trials Network (3CTN). In addition, she provided visionary leadership for the inaugural Canadian Cancer Research Conference (CCRC) and ensured its tradition as a forum that brings together researchers of all stripes to encourage dialogue and spark cross-disciplinary partnerships.

Although a clinician researcher, Dr. Eisenhauer has contributed her expertise to areas as diverse as tobacco control and palliative/end-of-life care and will continue, post-CCRA, to provide her wisdom and energy to these important areas within the cancer continuum. Best wishes, Elizabeth. The CCRA membership will miss you, but look forward to continued interactions during your ongoing activities.

Last Chance to Register!

The CCRA’s next Canadian Cancer Research Conference will be held November 5-7, 2017 at the Vancouver Convention Centre. The conference brings together the Canadian cancer research community spanning the research spectrum, from discovery research to policy research, and clinical research to end-of-life care. It also provides a venue for networking and cross-fertilization between research disciplines. The 2017 conference will build on the successes of previous meetings, which have each been attended by 1,000 delegates.

For more information or to register visit the CCRC website.

Other News and Events...

Opportunity at the Canadian Cancer Society - Vice President, Research

Reporting to the Executive Vice President, Research and Programs, the Vice-President, Research, provides overall scientific leadership and financial stewardship for the administration of the Society’s budget in research programs and initiatives to meet its strategic goals and research outcomes. This position is responsible for engaging the cancer research community to build researcher loyalty and support for CCS as a premier funder of cancer research in Canada. For more information, see

Opportunity: Scientist at the RIOH in Manitoba

The Research Institute in Oncology and Hematology (RIOH), a joint institute of CancerCare Manitoba and the University of Manitoba, invites applications for a full-time position as Scientist and appropriate level of Professor at the University of Manitoba beginning October, 2 2017 or as soon thereafter as possible.

This is a one-year appointment (October 2, 2017–October 1, 2018). Salary will be commensurate with qualifications and experience. Applications will be accepted until December, 31 2017 or until the position has been filled. For more information, click here.